Non-invasive method for assessing liver fibrosis progression
US10861582B2 · kind B2 · utility
Assignees
Inventor
Key dates
| Filing date | May 30, 2017 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | Jan 1, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7052
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for implementing an adapted patient care for an individual suffering from liver fibrosis after assessing liver fibrosis progression in the individual, and thus determining whether the individual is a slow, medium or fast fibroser. Also, a method for treating an individual suffering from liver fibrosis and identified as a fast fibroser, which includes the steps of identifying the individual as a fast fibroser by assessing fibrosis progression and treating the individual by administering without delay at least one therapeutic agent for treating liver fibrosis, or for treating the underlying cause responsible for liver fibrosis, or both.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.